Safety Profile, Side Effects, and Contraindications MOTS-c has a favorable safety profile in the published research to date, which is unsurprising given that it is an endogenous peptide that naturally circulates in human blood
Studies suggest that mechanistic interpretation is strongest when exposure time, formulation state, and control selection are kept constant
As such, they are widely expected to be the basis of a new way of fighting infection in place of antibiotics
Surgery: Bariatric surgery can help maintain weight by changing the digestive system, such as making the stomach smaller
Goal: Maximize sperm production while on testosterone therapy Approach: HCG 500 IU subcutaneously every other day Consider adding FSH or HMG if response insufficient after 3 months Semen analysis at baseline, 3 months, and 6 months Timeline: Initial testosterone response: 2-4 weeks Sperm appearance: 3-4 months Significant count improvement: 4-6 months If conception remains the urgent priority, discontinuing TRT while increasing HCG to 3000 IU every other day accelerates recovery
Clinical Weight Loss Results In a 12-week randomized clinical trial involving 300 obese adults, subjects receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg compared to 0.8 kg in the placebo group